HBK Sorce Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.13M | Buy |
20,828
+716
| +4% | +$154K | 0.1% | 79 |
|
|
2026
Q1 | $4.05M | Sell |
20,112
-338
| -2% | -$75K | 0.08% | 92 |
|
|
2025
Q4 | $4.57M | Sell |
20,450
-783
| -4% | -$178K | 0.1% | 82 |
|
|
2025
Q3 | $4.8M | Buy |
21,233
+238
| +1% | +$48.5K | 0.12% | 74 |
|
|
2025
Q2 | $3.9M | Buy |
20,995
+473
| +2% | +$87.9K | 0.11% | 84 |
|
|
2025
Q1 | $4.3M | Sell |
20,522
-294
| -1% | -$57.2K | 0.13% | 79 |
|
|
2024
Q4 | $3.7M | Buy |
20,816
+5
| +0% | +$919 | 0.11% | 83 |
|
|
2024
Q3 | $4.11M | Buy |
20,811
+150
| +0.7% | +$28K | 0.13% | 75 |
|
|
2024
Q2 | $3.54M | Sell |
20,661
-1,191
| -5% | -$197K | 0.12% | 81 |
|
|
2024
Q1 | $3.98M | Buy |
21,852
+150
| +0.7% | +$25.9K | 0.14% | 73 |
|
|
2023
Q4 | $3.36M | Sell |
21,702
-567
| -3% | -$82.7K | 0.13% | 82 |
|
|
2023
Q3 | $3.32M | Buy |
22,269
+668
| +3% | +$98.1K | 0.15% | 80 |
|
|
2023
Q2 | $2.91M | Sell |
21,601
-2,993
| -12% | -$439K | 0.12% | 98 |
|
|
2023
Q1 | $3.92M | Sell |
24,594
-27,806
| -53% | -$4.25M | 0.18% | 73 |
|
|
2022
Q4 | $8.47M | Buy |
52,400
+26,762
| +104% | +$4.1M | 0.23% | 61 |
|
|
2022
Q3 | $3.44M | Buy |
25,638
+4,329
| +20% | +$621K | 0.23% | 67 |
|
|
2022
Q2 | $3.26M | Sell |
21,309
-6,657
| -24% | -$1.02M | 0.24% | 59 |
|
|
2022
Q1 | $4.53M | Buy |
27,966
+1,877
| +7% | +$273K | 0.25% | 59 |
|
|
2021
Q4 | $3.53M | Buy |
26,089
+517
| +2% | +$61.1K | 0.18% | 85 |
|
|
2021
Q3 | $2.76M | Buy |
25,572
+1,745
| +7% | +$199K | 0.15% | 104 |
|
|
2021
Q2 | $2.68M | Buy |
23,827
+988
| +4% | +$111K | 0.15% | 106 |
|
|
2021
Q1 | $2.47M | Buy |
22,839
+427
| +2% | +$45.7K | 0.15% | 106 |
|
|
2020
Q4 | $2.4M | Buy |
22,412
+1,118
| +5% | +$107K | 0.15% | 99 |
|
|
2020
Q3 | $1.86M | Sell |
21,294
-462
| -2% | -$43.5K | 0.13% | 110 |
|
|
2020
Q2 | $2.14M | Buy |
21,756
+1,648
| +8% | +$145K | 0.16% | 94 |
|
|
2020
Q1 | $1.53M | Sell |
20,108
-386
| -2% | -$32.9K | 0.15% | 104 |
|
|
2019
Q4 | $1.81M | Buy |
20,494
+822
| +4% | +$68.2K | 0.16% | 110 |
|
|
2019
Q3 | $1.49M | Buy |
19,672
+660
| +3% | +$45.2K | 0.14% | 114 |
|
|
2019
Q2 | $1.38M | Buy |
19,012
+592
| +3% | +$46.5K | 0.13% | 118 |
|
|
2019
Q1 | $1.49M | Buy |
18,420
+35
| +0.2% | +$2.86K | 0.15% | 117 |
|
|
2018
Q4 | $1.7M | Buy |
18,385
+35
| +0.2% | +$3.08K | 0.19% | 102 |
|
|
2018
Q3 | $1.74M | Buy |
18,350
+396
| +2% | +$37.6K | 0.2% | 88 |
|
|
2018
Q2 | $1.66M | Sell |
17,954
-40
| -0.2% | -$3.91K | 0.19% | 87 |
|
|
2018
Q1 | $1.7M | Sell |
17,994
-1,262
| -7% | -$139K | 0.21% | 84 |
|
|
2017
Q4 | $1.86M | Buy |
19,256
+6,029
| +46% | +$568K | 0.22% | 83 |
|
|
2017
Q3 | $1.18M | Sell |
13,227
-937
| -7% | -$71.3K | 0.18% | 84 |
|
|
2017
Q2 | $1.03M | Buy |
+14,164
| New | +$952K | 0.16% | 92 |
|
|
2017
Q1 | – | Sell |
-13,228
| Closed | -$832K | – | 297 |
|
|
2016
Q4 | $828K | Buy |
13,228
+1,013
| +8% | +$61.8K | 0.15% | 106 |
|
|
2016
Q3 | $770K | Buy |
12,215
+835
| +7% | +$54.1K | 0.15% | 100 |
|
|
2016
Q2 | $705K | Sell |
11,380
-2,588
| -19% | -$158K | 0.15% | 102 |
|
|
2016
Q1 | $798K | Buy |
13,968
+3,169
| +29% | +$177K | 0.19% | 80 |
|
|
2015
Q4 | $640K | Sell |
10,799
-365
| -3% | -$21K | 0.17% | 92 |
|
|
2015
Q3 | $607K | Buy |
11,164
+2,449
| +28% | +$159K | 0.2% | 79 |
|
|
2015
Q2 | $586K | Buy |
8,715
+983
| +13% | +$64.2K | 0.2% | 87 |
|
|
2015
Q1 | $453K | Buy |
7,732
+394
| +5% | +$23.8K | 0.15% | 102 |
|
|
2014
Q4 | $480K | Buy |
7,338
+1,458
| +25% | +$91.9K | 0.17% | 99 |
|
|
2014
Q3 | $340K | Sell |
5,880
-253
| -4% | -$14K | 0.12% | 112 |
|
|
2014
Q2 | $346K | Sell |
6,133
-614
| -9% | -$32.2K | 0.12% | 115 |
|
|
2014
Q1 | $347K | Buy |
6,747
+185
| +3% | +$9.35K | 0.13% | 109 |
|
|
2013
Q4 | $347K | Sell |
6,562
-1,675
| -20% | -$82.3K | 0.12% | 112 |
|
|
2013
Q3 | $368K | Sell |
8,237
-10,941
| -57% | -$485K | 0.15% | 98 |
|
|
2013
Q2 | $792K | Buy |
+19,178
| New | +$839K | 0.17% | 89 |
|
Other funds holding ABBV
HBK Sorce Advisory's ABBV Position: Q2 2026 in Review
HBK Sorce Advisory increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $154K and bringing the position to 20,828 shares worth $5.13M. The position accounts for 0.1% of the portfolio, ranked #79.
HBK Sorce Advisory first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.47M in Q4 2022. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- HBK Sorce Advisory held 20,828 shares of AbbVie worth $5.13M as of Q2 2026.
- HBK Sorce Advisory bought 716 AbbVie shares in Q2 2026, an estimated $154K.
- AbbVie made up 0.1% of HBK Sorce Advisory's portfolio in Q2 2026, its #79 holding.
- HBK Sorce Advisory first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- HBK Sorce Advisory's AbbVie position peaked at $8.47M in Q4 2022.
- 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.